US 8518938
c-MET protein kinase inhibitors
granted A61PA61P11/00A61P35/00
Quick answer
US patent 8518938 (c-MET protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P11/00, A61P35/00, A61P35/02, A61P35/04